Literature DB >> 3355306

The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home.

N H Arden1, P A Patriarca, M B Fasano, K J Lui, M W Harmon, A P Kendal, D Rimland.   

Abstract

An outbreak caused by influenza A/Philippines/2/82 (H3N2)-like viruses occurred in a partially vaccinated nursing home population in January 1985. During the first six days of the outbreak, 14 (25%) of 55 residents developed influenzalike illness. The risk of illness was most strongly associated with undetectable levels of antibody against the epidemic strain, with unvaccinated case-patients having more severe illnesses and a higher rate of hospitalization than vaccinated case-patients (5/8 vs 0/6). During the period of amantadine hydrochloride prophylaxis (100 mg/d) from days 7 to 35, only two (5%) of the remaining 41 residents became ill, even though 11 (27%) had no detectable antibody. Serum amantadine levels obtained on day 35 ranged from 117 to 737 ng/mL (mean 309 ng/mL), similar to therapeutic levels documented in younger adults who have taken the standard regimen of 200 mg/d; there were few clinically significant side effects. These findings illustrate the benefits of influenza vaccination and support the use of amantadine hydrochloride at a dosage of 100 mg daily for outbreak control among elderly persons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355306

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  18 in total

1.  Surveillance for outbreaks of respiratory tract infections in nursing homes.

Authors:  M Loeb; A McGeer; M McArthur; R W Peeling; M Petric; A E Simor
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

Review 2.  Medical care of the elderly in the nursing home.

Authors:  P Starer; L S Libow
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

3.  Use of antiviral prophylaxis in influenza outbreaks in long term care facilities.

Authors:  A McGeer; D S Sitar; S E Tamblyn; K Faron; P Orr; F Y Aoki
Journal:  Can J Infect Dis       Date:  2000-07

Review 4.  The clinical efficacy of influenza vaccination.

Authors:  A S Monto
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

5.  Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.

Authors:  R J Fenton; P J Morley; I J Owens; D Gower; S Parry; L Crossman; T Wong
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Attitudes and behavior of health care personnel regarding influenza vaccination.

Authors:  D Ballada; L R Biasio; G Cascio; D D'Alessandro; I Donatelli; G M Fara; T Pozzi; M L Profeta; S Squarcione; D Riccò
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

7.  Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

Authors:  C G Stevenson; M A McArthur; M Naus; E Abraham; A J McGeer
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

8.  Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients.

Authors:  G P Leonardi; H Leib; G S Birkhead; C Smith; P Costello; W Conron
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 9.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

Review 10.  Antivirals for influenza: what is their role in the older patient?

Authors:  Ghinwa Dumyati; Ann R Falsey
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.